/* Find-A-Doctor RTM Jose Pedraza | v2.0.0 | Last Updated: 2014-08-08 | Jose Pedraza */

Accessibility Toolbar

UHealth Tower

Sandra Chaparro

Sandra Chaparro, M.D.

General Information

Sandra  Chaparro, M.D.





  • Cardiology-Internal Medicine
  • Advanced Heart Failure & Transplant Cardiology-Int Med
  • Internal Medicine


English, Spanish

Clinical Areas

Heart Transplantation.
Advanced Heart Failure.
Mechanical assist devices (LVADs).
Percutaneous assist devices.
Invasive cardiology.
Pulmonary Hypertension.




  • Amer Bd of IM-Advanced Heart Failure & Transplant Cardiology
  • American Board of Internal Med-Cardiovascular Disease


  • Associate Professor of Medicine
  • Director of Heart Failure Clinic
  • Director of Heart Failure/Transplant Fellowship Program
  • Heart Failure and Transplant Program

Research Interests

Current Trials:
Principal Investigator: MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3, IDE Study
Principal Investigator. CardioMEMS HF System Post Approval Study
Principal Investigator. Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Principal Investigator. C-Pulse Heart Assist Device pivotal study treating patients with moderate to Severe Heart Failure C-Pulse® System: A Heart Assist Device Pivotal IDE Study
Principal Investigator. A doubled blind, Randomized Efficacy and Safety Study of Allogenic Mesenchymal Precursors Cells (CEP-41750) in Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction. Phase 3. 
Co-PI.  Heartmate PHP™ Coronary Interventions in High-Risk Patients Using a Novel Percutaneous Left Ventricular Support Device (SHIELD II)
Co-PI. A Randomized, Double-Blind, Placebo-controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat (0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg TID) in Patients with Symptomatic Pulmonary Hypertension associated with Idiopathic Interstitial Pneumonias (IIP)
Co-PI. Gene Expression Profiling and Prognosis in Cardiomyopathy

Co-PI. Safety and Efficacy of Tafamidis in Patients with Transthyretin Cardiomyopathy (ATTR-ACT)



Dr. Chaparro becomes first in Southeast U.S. to use new heart monitoring device.


2008 Heart Failure and Transplantation Fellowship
Cleveland Clinic
2007 Cardiology Fellowship
University of Missouri
2004 Internal Medicine Residency
University of Missouri
2001 Infectious Diseases Fellowship
Stanford University


Dr. Chaparro is an expert in the management of critically ill heart failure patients, cardiac transplant patients, and patients who required mechanical support cardiac devices, including ventricular assist devices and total artificial heart. While there are some cardiologists who manage heart failure, clinical expertise in the management of advanced heart failure is exceptional and limited to those, like Dr. Chaparro, who have performed advanced training. She developed expert procedural skills in the performance of endomyocardial biopsies, heart catheterizations, implanting defibrillators, placement of intra-aortic balloon pumps and percutaneous support devices such as the Impella. She is the principal investigator of multiple clinical trials involving left ventricular devices, new pharmaceutical agents for cardiomyopathies and pulmonary hypertension, innovative heart assist device, spinal cord neuromodulation therapy and stem cell therapy.